Provectus Biopharmaceuticals,'s ticker is PVCT and the CUSIP is 74373F100. A total of 2 filers reported holding Provectus Biopharmaceuticals, in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRINCETON CAPITAL MANAGEMENT LLC | 25,000 | $60,000 | 0.05% |
| Livingston Group Asset Management CO (operating as Southport Capital Management) | 25,000 | $60,000 | 0.04% |
| AMG National Trust Bank | 11,500 | $28,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 3,900 | $9,000 | 0.00% |